| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.22 | 4e-09 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.18 | 8e-08 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.2 | 6e-06 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 8e-06 |